Dr. Kerr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5939 Harry Hines Blvd 7th floor Suite 700
Dallas, TX 75390Phone+1 214-645-1919Fax+1 214-645-1901
Summary
- Dr. Thomas Kerr is a gastroenterologist in Dallas, TX and is affiliated with multiple hospitals in the area, including University of Texas Southwestern Medical Center, William P. Clements, Jr. University Hospital, and Parkland Health & Hospital System. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 13 years. He specializes in hepatology & liver transplantation and is experienced in hepatology and colorectal cancer. He has more than 10 publications and over 500 citings.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 2006 - 2009
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2006
- University of Texas Southwestern Medical SchoolClass of 2004
Certifications & Licensure
- TX State Medical License 2014 - 2026
- MO State Medical License 2006 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- 1160 citationsMolecular basis for feedback regulation of bile acid synthesis by nuclear receptors.Timothy T. Lu, Makoto Makishima, Joyce J. Repa, Kristina Schoonjans, Thomas A. Kerr
Molecular Cell. 2000-09-01 - 145 citationsIDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in MiceAmeet I. Thaker, M. Suprada Rao, Kumar S. Bishnupuri, Thomas A. Kerr, Lynne Foster
Gastroenterology. 2013-08-01 - 264 citationsLoss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.Thomas A. Kerr, Shigeru Saeki, Manfred Schneider, Karen Schaefer, Sara Berdy
Developmental Cell. 2002-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: